TROUGH INFLIXIMAB LEVELS AND ANTI-INFLIXIMAB ANTIBODIES IN SPONDYLOARTHRITIS PATIENTS ON TREATMENT WITH LOW DOSE INFLIXIMAB: A SINGLE CENTRE CROSS-SECTIONAL STUDY

被引:0
|
作者
Patil, A. [1 ]
Upadhyaya, S. K. [1 ]
Dawar, R. [2 ]
Vaishnav, B. [1 ]
Dadhaniya, N. [1 ]
Gupta, S. J. [1 ]
Handa, R. [1 ]
机构
[1] Indraprastha Apollo Hosp, Rheumatol, Delhi, India
[2] Indraprastha Apollo Hosp, Microbiol, Delhi, India
关键词
D O I
10.1136/annrheumdis-2017-eular.2690
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
AB0683
引用
收藏
页码:1292 / 1292
页数:1
相关论文
共 50 条
  • [31] ESTABLISHING CUT-OFF OF INFLIXIMAB LEVELS AND ANTI-INFLIXIMAB ANTIBODIES BY COMMERCIAL ELISA IN PATIENTS WITH RHEUMATOID ARTHRITIS
    Hernandez, Diana
    Valor, Lara
    de la Torre, Inmaculada
    Martinez, Lina
    Carlos Nieto, Juan
    del Rio, Tamara
    Naredo, Esperanza
    Gonzalez, Carlos
    Lopez-Longo, Javier
    Montoro, Maria
    Monteagudo, Indalecio
    Carreno, Luis
    ANNALS OF THE RHEUMATIC DISEASES, 2014, 73 : A11 - A11
  • [32] Influence of anti-infliximab antibodies and residual infliximab concentrations on the occurrence of acquired drug resistance to infliximab in rheumatoid arthritis patients
    Finckh, Axel
    Dudler, Jean
    Wermelinger, Felix
    Ciurea, Adrian
    Kyburz, Diego
    Gabay, Cem
    Bas, Sylvette
    JOINT BONE SPINE, 2010, 77 (04) : 313 - 318
  • [33] CLINICAL RELEVANCE OF MEASURING FREE VERSUS TOTAL ANTI-INFLIXIMAB ANTIBODIES IN PATIENTS WITH SPONDYLOARTHRITIS
    Ruiz del Agua, A.
    Pascual, J.
    Torres, N.
    Pascual-Salcedo, D.
    Martinez, A.
    Jurado, T.
    Plasencia, C.
    Balsa, A.
    Ruiz-Arguello, B.
    Maguregui, A.
    Ametzazurra, A.
    Martinez, A.
    Nagore, D.
    ANNALS OF THE RHEUMATIC DISEASES, 2016, 75 : 1128 - 1129
  • [34] Exploring the Binding Sites of Anti-Infliximab Antibodies in Pediatric Patients With Rheumatic Diseases Treated With Infliximab
    Kosmac, Miha
    Avcin, Tadej
    Toplak, Natasa
    Simonini, Gabriele
    Cimaz, Rolando
    Serbec, Vladka Curin
    PEDIATRIC RESEARCH, 2011, 69 (03) : 243 - 248
  • [35] Monitoring patients treated with anti-TNF- biopharmaceuticals: assessing serum infliximab and anti-infliximab antibodies
    Svenson, M.
    Geborek, P.
    Saxne, T.
    Bendtzen, K.
    RHEUMATOLOGY, 2007, 46 (12) : 1828 - 1834
  • [36] Letter: persistence of anti-infliximab antibodies after discontinuation of infliximab in patients with IBD - authors' reply
    Ben-Horin, S.
    Chowers, Y.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2012, 36 (05) : 501 - 501
  • [37] Exploring the Binding Sites of Anti-Infliximab Antibodies in Pediatric Patients With Rheumatic Diseases Treated With Infliximab
    Miha Kosmač
    Tadej Avčin
    Nataša Toplak
    Gabriele Simonini
    Rolando Cimaz
    Vladka Čurin Šerbec
    Pediatric Research, 2011, 69 : 243 - 248
  • [38] Letter: detection of infliximab levels and anti-infliximab antibodies - comparison of three different assays; authors' reply
    Buurman, D. J.
    Vande Casteele, N.
    Sturkenboom, M. G. G.
    Kleibeuker, J. H.
    Vermeire, S.
    van der Kleij, D.
    Rispens, T.
    Gils, A.
    Dijkstra, G.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2013, 37 (02) : 282 - 282
  • [39] Serum Levels of Infliximab and Anti-Infliximab Anti-bodies in Brazilian Patients with Crohn's Disease
    Miani Gomes, Luis Eduardo
    Ramos da Silva, Francesca Aparecida
    Pascoal, Livia Bitencourt
    Ricci, Renato Lazarin
    Nogueira, Guilherme
    Camargo, Michel Gardere
    Setsuko Ayrizono, Maria de Lourdes
    Fagundes, Joao Jose
    Leal, Raquel Franco
    CLINICS, 2019, 74
  • [40] Trough s-infliximab and antibodies towards infliximab in a cohort of 79 IBD patients with maintenance infliximab treatment
    Marits, Per
    Landucci, Laura
    Sundin, Ulf
    Davidsdottir, Loa
    Nilsson, Jakob
    Befrits, Ragnar
    Wikstrom, Ann-Charlotte
    Eberhardson, Michael
    JOURNAL OF CROHNS & COLITIS, 2014, 8 (08): : 881 - 889